Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Kayvanpour

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
EMBO Molecular Medicine|January 24, 2013
Alterations in cardiac DNA methylation in human dilated cardiomyopathyJan Haas, Karen S Frese, Yoon Jung Park, et al.
International Journal of Cardiology|July 10, 2021
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)Elham Kayvanpour, Arjan Sammani, Farbod Sedaghat-Hamedani, et al.
European Heart Journal|October 14, 2017
Clinical genetics and outcome of left ventricular non-compaction cardiomyopathyFarbod Sedaghat-Hamedani, Jan Haas, Feng Zhu, et al.
JAMA Oncology|March 6, 2020
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic PatientsTobias Fehlmann, Mustafa Kahraman, Nicole Ludwig, et al.
European Heart Journal|August 29, 2014
Atlas of the clinical genetics of human dilated cardiomyopathyJan Haas, Karen S Frese, Barbara Peil, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
EMBO Molecular Medicine|January 24, 2013
Alterations in cardiac DNA methylation in human dilated cardiomyopathyJan Haas, Karen S Frese, Yoon Jung Park, et al.
International Journal of Cardiology|July 10, 2021
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)Elham Kayvanpour, Arjan Sammani, Farbod Sedaghat-Hamedani, et al.
European Heart Journal|October 14, 2017
Clinical genetics and outcome of left ventricular non-compaction cardiomyopathyFarbod Sedaghat-Hamedani, Jan Haas, Feng Zhu, et al.
JAMA Oncology|March 6, 2020
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic PatientsTobias Fehlmann, Mustafa Kahraman, Nicole Ludwig, et al.
European Heart Journal|August 29, 2014
Atlas of the clinical genetics of human dilated cardiomyopathyJan Haas, Karen S Frese, Barbara Peil, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
Pageof 7